Peri-operative use of EPO;Érythropoïéhtine en péri-opératoire

Transfusion Clinique et Biologique

Volumn 10, Issue 3, 2003, Pages 159-164

  Rosencher, N ^a   Ozier, Y ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Autologous blood transfusion; Erythropo etin; Hematocrit

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; BLEEDING; BLOOD AUTOTRANSFUSION; CASE REPORT; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDICATION; DRUG USE; HEMATOCRIT; HUMAN; IRON THERAPY; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PUERPERIUM; QUALITY OF LIFE; ALLOTRANSPLANTATION; BLOOD TRANSFUSION; ERYTHROCYTE COUNT; METABOLISM; PEROPERATIVE CARE; REVIEW; SAFETY;

ANEMIA; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROCYTE COUNT; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINS; HUMANS; INTRAOPERATIVE CARE; SAFETY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038039009     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(03)00057-0     Document Type: Conference Paper

References (17)

1. Erslev AJ. Erythropoietin. N Engl J Med 1991;324:1339-44.
2. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13(8):465-78.
3. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Pre-operative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32(5):441-5.
4. Goodnough L, Monk T, Andriole G. Erythropoietin therapy. N Engl J Med 1997;336:933-8.
5. Goodnough LT, Rudnick S, Price TH, et al. Increased pre-operative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321(17):1163-8.
6. De Pree C, Mermillod B, Hoffmeyer P, Beris P. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation in elective surgery with large blood needs (> or = 5 units): a randomized study. Transfusion 1997;37:708-14.
7. Walpoth B, Galliker B, Spirig P, et al. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol 1997;33:75-6.
8. Price T, Goodnough L, Vogler W, et al. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 1996;101:22S-7S.
9. Canadian, Orthopedic, Perioperative, Erythropoietin, Group S. Effectivcness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;341:1227-32.
10. Mercuriali F. EPOetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. Semin Hematol 1997;33:10-2.
11. Faris P. Use of recombinant human erythropoietin in the peri-operative period of orthopedic surgery. Am J Med 1996;101:28S-32S.
12. Goldberg M. Perioperative epoietin alfa increases red blood cell mass and reduces exposure to transfusions: Results of randomised clinical trials. Semin Hematol 1997;34:41-7.
13. Rosencher N, Samama C, Albi A, et al. Epoietin alpha (Épo) vs TAP séquentielle en chirurgie orthopédique. Ann Fr Anesth Réanim 2001;20(suppl 1):183.
14. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332(11):719-24.
15. Birkmeyer JD, Goodnough LT, Aubuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544-51.
16. Houston F, Foster J, Chong A, Hunter N, Bostock C. Transmission of BSE by blood transfusion in sheep. Lancet 2000 september 16;356:999-2000.
17. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (Ispot) Investigators. Transfus Med 1998;8(4):309-17.